David Claxton
0000-0001-9209-2405
Penn State Milton S Hershey Medical Center
5 papers found
Refreshing results…
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia
Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity
Missing publications? Search for publications with a matching author name.